Max Moldovan
School of Agriculture, Food and Wine
Faculty of Sciences, Engineering and Technology
Max Moldovan, PhD is an applied statistician/data scientist working in the fields of methodological research and data analysis in life sciences. Max obtained his PhD in statistics from the University of Melbourne in 2008, followed by the postdoctoral training in the Walter and Eliza Hall Research Institute of Medical Research (WEHI). Over his career, Max led and contributed to various research projects with a major tangible impact nationally and internationally. Since 2014 and before joining the Biometry Hub in July 2021, Max was employed firstly as a Lead Bioinformatician and later as a Senior Data Scientist by the South Australian Health and Medical Research Institute (SAHMRI), where he was a recipient of the Research Translation Award and High-impact Publication Award, in 2019 and 2020, respectively.
For the current research and methodological interests, Max is particularly interested in exact, unbiased and efficient inference, including causal inference, from observational and routinely collected datasets, related statistical learning methods and generalised additive modelling approaches.
-
Appointments
Date Position Institution name 2016 - 2021 Bioinformatician/Senior Data Scientist South Australian Health and Medical Research Institute 2014 - 2016 Senior Research Fellow University of South Australia 2010 - 2013 Research Fellow UNSW Australia 2008 - 2010 Postdoctoral Fellow Walter and Eliza Hall Institute of Medical Research -
Education
Date Institution name Country Title 2005 - 2008 University of Melbourne Australia PhD 2001 - 2003 Queensland University of Technology Australia Master of Business (research) -
Research Interests
Aged Health Care Agricultural Spatial Analysis and Modelling Agricultural Systems Analysis and Modelling Antimicrobial Resistance Applied Statistics Artificial Intelligence Autoimmunity Bioinformatics Biostatistics Cancer Genetics Genetics Health Informatics Health Policy Medical and Health Sciences Medical Genetics Medical Informatics Panel Data Analysis Pattern Recognition and Data Mining Pharmaceutical Sciences Pharmacogenomics Population Health Public Health Public Health and Health Services Statistics
-
Journals
Year Citation 2023 Eshetie, T. C., Moldovan, M., Caughey, G. E., Lang, C., Sluggett, J. K., Khadka, J., . . . Inacio, M. C. (2023). Development of a Multivariable Prediction Model for Risk of Hospitalization With Pressure Injury After Entering Residential Aged Care. Journal of the American Medical Directors Association (JAMDA): long-term care: management, applied research and clinical issues, 24(3), 299-306.e9.
2022 Centenera, M. M., Vincent, A. D., Moldovan, M., Lin, H. M., Lynn, D. J., Horvath, L. G., & Butler, L. M. (2022). Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived Explants. Cancers, 14(7), 1708-1-1708-18.
Scopus12022 Sluggett, J. K., Caughey, G. E., Air, T., Moldovan, M., Lang, C., Martin, G., . . . Inacio, M. C. (2022). Medicines use before and after comprehensive medicines review among residents of long-term care facilities: a retrospective cohort study. BMC Geriatrics, 22(1), 493-1-493-15.
Scopus3 WoS2 Europe PMC12022 Sluggett, J. K., Caughey, G. E., Air, T., Moldovan, M., Lang, C., Martin, G., . . . Inacio, M. C. (2022). Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study. Age and Ageing, 51(7), afac149-1-afac149-11.
Scopus3 WoS3 Europe PMC22022 Nechval, N. A., Berzins, G., Nechval, K. N., Tsaurkubule, Z., & Moldovan, M. (2022). A New Intelligent Method for Eliminating Unknown (Nuisance) Parameters from Underlying Models as an Alternative to the Bayesian Approach. Journal of Applied Mathematics and Computation, 6(1), 53-65.
2021 Jiang, S. H., Mercan, S., Papa, I., Moldovan, M., Walters, G. D., Koina, M., . . . Vinuesa, C. G. (2021). Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease.. Cell reports. Medicine, 2(12), 14 pages.
Europe PMC12021 Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S., . . . Swinnen, J. V. (2021). Lipidomic profiling of clinical prostate cancer reveals targetable alterations in membrane lipid composition. Cancer Research, 81(19), 4981-4993.
Scopus18 WoS17 Europe PMC192021 Sluggett, J. K., Moldovans, M., Lang, C., Lynn, D. J., Papanicolas, L. E., Crotty, M., . . . Inacio, M. C. (2021). Contribution of facility level factors to variation in antibiotic use in long-term care facilities: a national cohort study. The Journal of Apyntimicrobial Chemothera, 76(5), 1339-1348.
Scopus4 WoS5 Europe PMC32021 Sluggett, J. K., Moldovan, M., Lynn, D. J., Papanicolas, L. E., Crotty, M., Whitehead, C., . . . Inacio, M. C. (2021). National trends in antibiotic Use in Australian residential aged care facilities, 2005-2016. Clinical Infectious Diseases, 72(12), 2167-2174.
Scopus7 WoS3 Europe PMC82021 Gillis, J. L., Hinneh, J. A., Ryan, N. K., Irani, S., Moldovan, M., Quek, L. -E., . . . Shrestha, R. (2021). A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth.. eLife, 10, 27 pages.
Scopus9 WoS9 Europe PMC92021 Inacio, M. C., Moldovan, M., Whitehead, C., Sluggett, J. K., Crotty, M., Corlis, M., . . . Caughey, G. E. (2021). The risk of fall-related hospitalisations at entry into permanent residential aged care. BMC Geriatrics, 21(1), 686-1-686-13.
Scopus7 WoS6 Europe PMC32020 Moldovan, M., Khadka, J., Visvanathan, R., Wesselingh, S., & Inacio, M. C. (2020). Using elastic nets to estimate frailty burden from routinely collected national aged care data. Journal of the American Medical Informatics Association, 27(3), 419-428.
Scopus8 WoS8 Europe PMC32020 Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (2020). Fatty acid oxidation is an adaptive survival pathway induced in prostate tumors by heat shock protein 90 inhibition. Molecular cancer research : MCR, 18(10), 1500-1511.
Scopus6 WoS6 Europe PMC52020 Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J., Irani, S., Centenera, M. M., . . . Butler, L. M. (2020). Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis. Elife, 9, 1-34.
Scopus59 WoS56 Europe PMC392020 Khadka, J., Visvanathan, R., Theou, O., Moldovan, M., Amare, A. T., Lang, C., . . . Inacio, M. C. (2020). Development and validation of a frailty index based on Australian Aged Care Assessment Program data. Medical Journal of Australia, 213(7), 321-326.
Scopus16 WoS17 Europe PMC92020 Tomita, Y., Moldovan, M., Chang Lee, R., Hsieh, A. H., Townsend, A., & Price, T. (2020). Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma. The Cochrane database of systematic reviews, 2020(11), 121 pages.
Scopus3 Europe PMC72020 Tomita, Y., Moldovan, M., Lee, R. C., Hsieh, A. H. C., Townsend, A., & Price, T. (2020). Salvage systemic therapy for advanced gastric and oesophagogastric junction adenocarcinoma. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (11), 122 pages.
WoS62019 Charitou, T., Srihari, S., Lynn, M. A., Jarboui, M. A., Fasterius, E., Moldovan, M., . . . Lynn, D. J. (2019). Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS<sup>G13D</sup> mutation. British Journal of Cancer, 121(1), 37-50.
Scopus28 WoS29 Europe PMC212019 Ryan, F. J., Drew, D. P., Douglas, C., Leong, L. E. X., Moldovan, M., Lynn, M., . . . Lynn, D. J. (2019). Changes in the composition of the gut microbiota and the blood transcriptome in preterm infants at less than 29 weeks gestation diagnosed with bronchopulmonary dysplasia. mSystems, 4(5), e00484-19-1-e00484-19-17.
Scopus21 WoS20 Europe PMC112019 Schmidt, A. F., Holmes, M. V., Preiss, D., Swerdlow, D. I., Denaxas, S., Fatemifar, G., . . . Dehghan, A. (2019). Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9. BMC Cardiovascular Disorders, 19(1), 10 pages.
Scopus16 WoS12 Europe PMC132019 Liu, Y. C., Nguyen, P. A., Humayun, A., Chien, S. C., Yang, H. C., Asdary, R. N., . . . Iqbal, U. (2019). Does long-term use of antidiabetic drugs changes cancer risk?. Medicine (United States), 98(40), 9 pages.
Scopus13 WoS10 Europe PMC62018 Armstrong, H., Gillis, J., Johnson, I., Nassar, Z., Moldovan, M., Levrier, C., . . . Butler, L. (2018). Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion. Scientific reports, 8(1), 2090-1-2090-14.
Scopus23 WoS24 Europe PMC172018 Dent, E., Hoogendijk, E., & Moldovan, M. (2018). Frailty index from routine laboratory measurements correlates with leukocyte telomere length. Geriatrics and Gerontology International, 18(4), 654-655.
Scopus6 WoS4 Europe PMC22018 Nguyen, E., Centenera, M., Moldovan, M., Das, R., Irani, S., Vincent, A., . . . Butler, L. (2018). Identification of novel response and predictive biomarkers to Hsp90 inhibitors through mass spectrometry-based proteomic profiling of patient-derived prostate tumor explants. Molecular & cellular proteomics : MCP, 17(8), 1470-1486.
Scopus23 WoS24 Europe PMC132017 Schmidt, A. F., Swerdlow, D. I., Holmes, M. V., Patel, R. S., Fairhurst-Hunter, Z., Lyall, D. M., . . . Völker, U. (2017). PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. The Lancet Diabetes and Endocrinology, 5(2), 97-105.
Scopus250 WoS233 Europe PMC1602017 Dale, C., Fatemifar, G., Palmer, T., White, J., Prieto-Merino, D., Zabaneh, D., . . . Casas, J. (2017). Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis. Circulation, 135(24), 2373-2388.
Scopus215 WoS215 Europe PMC1542017 Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., . . . King, C. (2017). Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study. Pharmacogenomics Journal, 17(4), 312-318.
Scopus22 WoS18 Europe PMC92017 Iqbal, U., Chang, T. H., Nguyen, P. A., Syed-Abdul, S., Yang, H. C., Huang, C. W., . . . Li, Y. C. (2017). Benzodiazepines use and breast cancer risk: A population-based study and gene expression profiling evidence. Journal of Biomedical Informatics, 74, 85-91.
Scopus4 WoS4 Europe PMC12016 Jacobsen, R., Moldovan, M., Vaag, A. A., Hypponen, E., & Heitmann, B. L. (2016). Erratum: Vitamin D fortification and seasonality of birth in type 1 diabetic cases: D-tect study (Journal of Developmental Origins of Health and Disease (2016) 7 (114-119) DOI: 10.1017/S2040174415007849). Journal of Developmental Origins of Health and Disease, 7(4), 429.
Scopus32016 Larsen, S. C., Ängquist, L., Moldovan, M., Huikari, V., Sebert, Y., Cavadino, A., . . . Sørensen, T. I. A. (2016). Serum 25-hydroxyvitamin D status and longitudinal changes in weight and waist circumference: Influence of genetic predisposition to adiposity. PLoS ONE, 11(4), 1-18.
Scopus8 WoS9 Europe PMC52016 Jacobsen, R., Moldovan, M., Vaag, A. A., Hypponen, E., & Heitmann, B. L. (2016). Vitamin D fortification and seasonality of birth in type 1 diabetic cases: D-tect study. Journal of Developmental Origins of Health and Disease, 7(1), 114-119.
Scopus10 Europe PMC72015 Syed-Abdul, S., Moldovan, M., Nguyen, P. A., Enikeev, R., Jian, W. S., Iqbal, U., . . . Li, Y. C. (2015). Profiling phenome-wide associations: A population-based observational study. Journal of the American Medical Informatics Association, 22(4), 896-899.
Scopus6 WoS4 Europe PMC32014 Davey Smith, G., Hyppönen, E., Moldovan, M., & Power, C. (2014). Death of siblings in childhood and subsequent mortality: prospective observational study. European Journal of Epidemiology, 29(11), 859-861.
Scopus2 WoS2 Europe PMC22014 Moldovan, M., Enikeev, R., Syed-Abdul, S., Nguyen, P. A., Chang, Y. C., & Li, Y. C. (2014). Disease universe: Visualisation of population-wide disease-wide associations. Advances in Systems Science and Applications, 14(2), 144-158.
Scopus42014 Moldovan, M., & Langaas, M. (2014). Exact conditional efficiency robust P-values from an arbitrary ranking of a sample space: An application to genome-wide association studied. Advances in Systems Science and Applications, 14(1), 79-86.
Scopus12013 Shaw, C. D., Braithwaite, J., Moldovan, M., Nicklin, W., Grgic, I., Fortune, T., & Whittaker, S. (2013). Profiling health-care accreditation organizations: An international survey. International Journal for Quality in Health Care, 25(3), 222-231.
Scopus57 WoS50 Europe PMC322013 Mumford, V., Greenfield, D., Hinchcliff, R., Moldovan, M., Forde, K., Westbrook, J. I., & Braithwaite, J. (2013). Economic evaluation of Australian acute care accreditation (ACCREDIT-CBA (Acute)): Study protocol for a mixedmethod research project. BMJ Open, 3(2), 8 pages.
Scopus15 WoS13 Europe PMC82013 Mahurkar, S., Moldovan, M., Suppiah, V., & O'Doherty, C. (2013). Identification of Shared Genes and Pathways: A Comparative Study of Multiple Sclerosis Susceptibility, Severity and Response to Interferon Beta Treatment. PLoS ONE, 8(2), 9 pages.
Scopus16 WoS15 Europe PMC132012 Braithwaite, J., Shaw, C. D., Moldovan, M., Greenfield, D., Hinchcliff, R., Mumford, V., . . . Whittaker, S. (2012). Comparison of health service accreditation programs in low- and middle-income countries with those in higher income countries: A cross-sectional study. International Journal for Quality in Health Care, 24(6), 568-577.
Scopus44 WoS40 Europe PMC232012 Greenfield, D., Hinchcliff, R., Moldovan, M., Mumford, V., Pawsey, M., Westbrook, J. I., & Braithwaite, J. (2012). A multimethod research investigation of consumer involvement in Australian health service accreditation programmes: The ACCREDIT-SCI study protocol. BMJ Open, 2(5), 7 pages.
Scopus15 WoS10 Europe PMC82012 Hinchcliff, R., Greenfield, D., Moldovan, M., Westbrook, J. I., Pawsey, M., Mumford, V., & Braithwaite, J. (2012). Narrative synthesis of health service accreditation literature. BMJ Quality and Safety, 21(12), 979-991.
Scopus136 WoS128 Europe PMC802012 Greenfield, D., Pawsey, M., Hinchcliff, R., Moldovan, M., & Braithwaite, J. (2012). The standard of healthcare accreditation standards: A review of empirical research underpinning their development and impact. BMC Health Services Research, 12(1), 14 pages.
Scopus59 WoS55 Europe PMC402012 Hinchcliff, R., Greenfield, D., Moldovan, M., Pawsey, M., Mumford, V., Westbrook, J. I., & Braithwaite, J. (2012). Evaluation of current Australian health service accreditation processes (ACCREDIT-CAP): Protocol for a mixed-method research project. BMJ Open, 2(4), 7 pages.
Scopus17 WoS12 Europe PMC92012 Greenfield, D., Hinchcliff, R., Westbrook, M., Jones, D., Low, L., Johnston, B., . . . Braithwaite, J. (2012). An empirical test of accreditation patient journey surveys: Randomized trial. International Journal for Quality in Health Care, 24(5), 495-500.
Scopus16 WoS15 Europe PMC112012 Hinchcliff, R., Westbrook, J., Greenfield, D., Baysari, M., Moldovan, M., & Braithwaite, J. (2012). Analysis of Australian newspaper coverage of medication errors. International Journal for Quality in Health Care, 24(1), 1-8.
Scopus12 WoS12 Europe PMC92012 Greenfield, D., Moldovan, M., Westbrook, M., Jones, D., Low, L., Johnston, B., . . . Braithwaite, J. (2012). An empirical test of short notice surveys in two accreditation programmes. International Journal for Quality in Health Care, 24(1), 65-71.
Scopus25 WoS24 Europe PMC182012 Nechval, K. N., Nechval, N. A., Purgailis, M., Rozevskis, U., Strelchonok, V. F., & Moldovan, M. (2012). Predictive inferences for a future number of failures coming from underlying models under parametric uncertainty. Advances in Systems Science and Applications, 12(4), 373-387. 2011 Braithwaite, J., Westbrook, J., Johnston, B., Clark, S., Brandon, M., Banks, M., . . . Moldovan, M. (2011). Strengthening organizational performance through accreditation research-a framework for twelve interrelated studies: The ACCREDIT project study protocol. BMC Research Notes, 4(1), 390.
Scopus32 Europe PMC222011 Lloyd, C. J., & Moldovan, M. V. (2011). Constructing more powerful exact tests of equivalence from binary matched pairs. Australian and New Zealand Journal of Statistics, 53(1), 27-42.
Scopus4 WoS32009 Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., . . . George, J. (2009). IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy. Nature Genetics, 41(10), 1100-1104.
Scopus1717 WoS1562 Europe PMC12622008 Lloyd, C. J., & Moldovan, M. V. (2008). A more powerful exact test of noninferiority from binary matched-pairs data. Statistics in Medicine, 27(18), 3540-3549.
Scopus31 WoS29 Europe PMC132007 Lloyd, C. J., & Moldovan, M. V. (2007). Exact one-sided confidence bounds for the risk ratio in 2 × 2 tables with structural zero. Biometrical Journal, 49(6), 952-963.
Scopus8 WoS5 Europe PMC22007 Lloyd, C. J., & Moldovan, M. V. (2007). Unconditional efficient one-sided confidence limits for the odds ratio based on conditional likelihood. Statistics in Medicine, 26(28), 5136-5146.
Scopus15 WoS11 Europe PMC32007 Lloyd, C. J., & Moldovan, M. V. (2007). Exact one-sided confidence limits for the difference between two correlated proportions. Statistics in Medicine, 26(18), 3369-3384.
Scopus18 WoS16 Europe PMC7- Moldovan, M., Radbone, C., & Inacio, M. C. (n.d.). Benchmarking Computational Performance of Virtual Machines Within the Secure Unified Research Environment Versus Physical Computers. International Journal of Population Data Science, 5(5).
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S2 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Supplementary Figures S1-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Data from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S1 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S3 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Data from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Supplementary Tables S2-S6 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Table S4 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Butler, L. M., Mah, C. Y., Machiels, J., Vincent, A. D., Irani, S., Mutuku, S. M., . . . Swinnen, J. V. (n.d.). Supplementary Table S1 from Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
- Nassar, Z. D., Mah, C. Y., Centenera, M. M., Irani, S., Sadowski, M. C., Scott, J. S., . . . Butler, L. M. (n.d.). Supplementary Figures and Legends 1-8 from Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition.
- Nassar, Z. D., Mah, C. Y., Dehairs, J., Burvenich, I. J. G., Irani, S., Centenera, M. M., . . . Butler, L. M. (n.d.). DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
- Moldovan, M., & Taylor, J. (n.d.). Elastic Net (Model Selection). Unknown Journal, 1-5.
-
Conference Papers
Year Citation 2020 Sluggett, J. K., Moldovan, M., Lynn, D. J., Papanicolas, L., Crotty, M., Whitehead, C., . . . Inacio, M. C. (2020). National Trends in Antibiotic Use in Australian Residential Aged Care Facilities, 2005-2016. In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY Vol. 68 (pp. S143). Long Beach, CA: WILEY.
WoS32013 Nechval, N. A., Nechval, K. N., Purgailis, M., Rozevskis, U., Danovich, V., Ribakova, N., . . . Moldovan, M. (2013). Solving the problems of inspection planning under parametric uncertainty of underlying models. In IFAC Proceedings Volumes (IFAC-PapersOnline) Vol. 46 (pp. 489-494). Elsevier BV.
2009 Moldovan, M., Suppiah, V., Booth, D., George, J., & Bahlo, M. (2009). Prediction Modeling in the Context of Pharmacogenomic Genome-wide Association Study: Identifying Non-responders to PegINF-alpha/ribavirin Treatment Among Chronic Genotype 1 Hepatitis C Virus Infected Individuals. In GENETIC EPIDEMIOLOGY Vol. 33 (pp. 808). Honolulu, HI: WILEY-LISS. -
Conference Items
Year Citation 2020 Mah, C. Y., Nassar, Z. D., Burvenich, I. J., Irani, S., Centenera, M. M., Moldovan, M., . . . Butler, L. M. (2020). DECR1: The rate limiting enzyme of polyunsaturated fatty acid metabolism and a novel therapeutic target in prostate cancer. Poster session presented at the meeting of CANCER RESEARCH. ELECTR NETWORK: AMER ASSOC CANCER RESEARCH.
2018 Dent, E., Hoogendijk, E., & Moldovan, M. (2018). Telomere length associates with a Frailty Index Based on Standard Laboratory Measurements (FI-LAB). Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY.
Connect With Me
External Profiles
